Chimonanthus salicifolius extract alleviates DSS‐induced colitis and regulates gut microbiota in mice

Lin Chen,Xin Li,Qing Gu
DOI: https://doi.org/10.1002/fsn3.3282
2023-03-18
Abstract:The intervention of C. salicifolius extract on colitis mice effectively regulated intestinal flora induced by DSS and restored their relative abundance. The extract group significantly increased the abundance and diversity of Lactobacillaceae compared with other treatments. Therefore, the results indicate that C. salicifolius extract presents the potential to be developed as a candidate for treating colitis. Ulcerative colitis is a chronic and recurrent gastrointestinal intestinal disease accompanied by inflammatory disorders, immunologic inadequacy, and intestinal flora dysbiosis, and current therapeutic pharmaceuticals have limited side effects. In this study, we revealed the extraction method of Chimonanthus salicifolius, analyzed the main component, compared the effect of its extract, Lactobacillus, and conventional drugs with different properties on DSS (dextran sodium sulfate)‐induced colitis, and indicated extract regulatory properties of inestinal flora. A colitis model was established on experimental design, and BALB/c mice (male, 7 weeks old) were randomly assigned to five groups (n = 10): control, DSS model, Chimonanthus salicifolius extract (CSE), Lactobacillus rhamnosus GG (LGG), and 5‐aminosalicylic acid (5‐ASA) groups. The three treatments could alleviate the symptoms and remit inflammation induced by DSS, in which CSE and LGG groups could both decrease the proinflammatory cytokine IL‐6, IL‐8, and TNF‐α levels and increase anti‐inflammatory cytokines IL‐10 and TGF‐β. The CSE intervention significantly promoted the higher production of butyric acid than LGG and 5‐ASA groups (p
food science & technology
What problem does this paper attempt to address?